In November, 79 new cases were added to the Ozempic MDL (Multidistrict Litigation), bringing the total number of filings to over 200 in just the past two months. The MDL now includes more than 1,300 pending cases which reflect the growing number of individuals who are looking for legal action due to negative effects linked to Ozempic.